vimarsana.com

Latest Breaking News On - Friedrich alexander university erlangen n - Page 1 : vimarsana.com

人類學 – 開欄文 - 時事論壇 - udn城市

人類學 – 開欄文 - 時事論壇 - udn城市
udn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from udn.com Daily Mail and Mail on Sunday newspapers.

人類學 – 開欄文 - 時事論壇 - udn城市

人類學 – 開欄文 - 時事論壇 - udn城市
udn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from udn.com Daily Mail and Mail on Sunday newspapers.

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin.

人類學 – 開欄文 - 時事論壇 - udn城市

人類學 – 開欄文 - 時事論壇 - udn城市
udn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from udn.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.